Radiation dose associated with renal failure mortality: A potential pathway to partially explain increased cardiovascular disease mortality observed after whole-body irradiation

Radiation Research

Volumn 177, Issue 2, 2012, Pages 220-228

  Adams, Michael Jacob ^a   Grant, Eric J ^b   Kodama, Kazunori ^b   Shimizu, Yukiko ^b   Kasagi, Fumiyoshi ^c   Suyama, Akihiko ^b   Sakata, Ritsu ^b   Akahoshi, Masazumi ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^c Maruishi Daini Bldg 5F   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INFANT; INFORMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; SCHOOL CHILD; SELF REPORT; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY BURDEN; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MIDDLE AGED; NUCLEAR WARFARE; PREVALENCE; RADIATION DOSAGE; RADIATION INJURIES; RENAL INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; SURVIVORS; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 84856471946     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2746.1     Document Type: Article

References (34)

1. Adams MJ, Hardenbergh P, Constine LS, Lipshultz SE. Radiationassociated cardiovascular disease. Crit Rev Oncol 2003; 45:55-75.
2. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment for Hodgkin's disease. JAMA 1993; 270:1949-55. (Pubitemid 23312611)
3. Mauch P, Kalish LA, Marcus KC, et al. Long-term survival in Hodgkin's disease: Relative impact of mortality, second tumors, infection and cardiovascular disease. Cancer J Sci Am 1995; 1:33-42.
4. Lee CK, Aeppli D, Nierengarten ME. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience. Int J Radiat Oncol Biol Phys 2000; 48:169-79. (Pubitemid 30488228)
5. Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the Surveillance, Epidemiology, and End-Results cancer registries. J Clin Oncol 1998; 16:2625-31. (Pubitemid 28363025)
6. Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: Population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 1993; 43:755-62.
7. Paszat LF, Vallis KA, Benk VM, Groome PA, Mackillop WJ, Wielgosz A. A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol 2007; 82:294-300. (Pubitemid 46341476)
8. Marks LB, Constine LS, Adams MJ. Cardiac effects of radiation therapy for malignancy. In: Basow DS, editor. UpToDate. Waltham, MA: UpToDate; 2011.
9. Carr ZA, Land CE, Kleinerman RA, Weinstock RW, Stovall M, Griem ML, et al. Coronary heart disease after radiotherapy for peptic ulcer disease. Int J. Radiat Oncol Biol Phys 2005; 61:842-50. (Pubitemid 40247980)
10. Muirhead CR, O'Hagan JA, Haylock RG, Phillipson MA, Willcock T, Berridge GL, et al. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br J Cancer 2009; 100:206-12.
11. Azizova TV, Muirhead CR, Druzhinina MB, Grigoryeva ES, Vlasenko MV, Sumina J, et al. Cardiovascular diseases in the cohort of workers first employed at Mayak PA in 1948-1958. Radiat Res 2010; 174:155-68.
12. Little MP, Tawn EJ, Tzoulaki I, Wakeford R, Hildebrandt G, Parris F, et al. Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat Environ Biophys 2010; 49:139-53.
13. Shimizu Y, Kato H, Schull WJ, Hoel DG. Studies of mortality of A-bomb survivors: Mortality 1950-1985. part 3: Noncancer mortality based on the revised doses. Radiat Res 1992; 130:249-66.
14. Shimizu Y, Pierce DA, Preston DL, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 12, part II. Non-cancer mortality:1950-1990. Radiat Res 1999; 152:374-89. (Pubitemid 29463615)
15. Preston DL, Pierce DA, Shimizu Y, Ron E, Mabuchi K. Dose response and temporal patterns of radiation-associated solid cancer risks. Health Phys 2003; 85:43-6. (Pubitemid 36706039)
16. Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ 2010; 340:b5349.
17. Wong FL, Yamada M, Sasaki H, Kodama K, Akiba S, Shimaoka K, et al. Non-cancer disease incidence in atomic bomb survivors. Radiat Res 1993; 135:418-30. (Pubitemid 23306530)
18. Kodama K, Fujiwara S, Yamada M, Kasagi F, Shimizu Y, Shigematsu I. Profiles of non-cancer disease in atomic bomb survivors. World Health Stat Q 1996; 49:7-16. (Pubitemid 26325096)
19. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res 2004; 161:622-32. (Pubitemid 39149570)
20. Sasaki H, Wong FL, Yamada M, Kodama K. The effects of aging and radiation exposure on blood pressure levels of atomic bomb survivors. J Clin Epidemiol 2002; 55:974-81. (Pubitemid 36018861)
21. Kal HB, Van Kempen-Harteveld ML. Induction of severe cataract and late renal dysfunction following total body irradiation: Doseeffect relationships. Anticancer Res 2009; 29:3305-9.
22. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program. JAMA 2001; 285:2486-97.
23. National Kidney Foundation, K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 Suppl 1:S1-266.
24. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003; 160:381-407. (Pubitemid 37174507)
25. Cullings HM, Fujita S, Funamoto S, Grant EJ, Kerr GD, Preston DL. Dose estimation for atomic bomb survivor studies: Its evolution and present status. Radiat Res 2006; 166:219-54. (Pubitemid 44051213)
26. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108:2154-69. (Pubitemid 37337595)
27. Mail questionnaire survey for epidemiologic data on the Life Span Study extended sample, 1978. RERF RP 14-78. Hiroshima: Radiation Effects Research Foundation; 1980.
28. Akiba S, Shibata Y, Kasagi F, Shimaoka K, Land CE, Yamada M, et al. Mail survey of epidemiologic factors in the extended Life Span Study, 1991. RERF RP 4-91. Hiroshima: Radiation Effects Research Foundation; 1992. p. 1-37.
29. Breslow NE, Day NE. Statistical methods in cancer research. Vol The design and analysis of cohort studies, Scientific Publication No. 82. Lyon: International Agency for Research Cancer on Cancer; 1987.
30. Preston DL, Lubin JH, Pierce DA. Epicure user's guide. Seattle, WA: Hirosoft; 1991.
31. Akaike H. A new look at statistical model identification. IEEE Trans Automat Control 1974; 19:716-23.
32. Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: A study of NHANES III. Kidney Int 2005; 67:685-90. (Pubitemid 40139861)
33. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. AHA/CDC scientific statement: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107:499-511. (Pubitemid 36158056)
34. Kusunoki Y, Hayashi T. Long-lasting alterations of the immune system by ionizing radiation exposure: Implications for disease development among atomic bomb survivors. Int J Radiat Biol 2008; 84:1-14. (Pubitemid 350208779)